Black Diamond Therapeutics, Inc. Common Stock (BDTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDTX trades at $3.64 with a market cap of $147.84M and a P/E ratio of 8.81. BDTX moved +20.00% today. Year to date, BDTX is +40.08%; over the trailing twelve months it is +65.90%. Its 52-week range spans $1.20 to $4.94. Analyst consensus is strong buy with an average price target of $10.25. Rallies surfaces BDTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Black Diamond Therapeutics, Inc. Common Stock (BDTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BDTX moved +20.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $3.64 |
| Market Cap | $147.84M |
| P/E Ratio | 8.81 |
| EPS | $0.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.94 |
| 52-Week Low | $1.20 |
| Volume | 7.86M |
| Avg Volume | 0 |
| Revenue (TTM) | $70.00M |
| Net Income | $22.37M |
| Gross Margin | 0.00% |
5 analysts cover BDTX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.25.